Cargando…

Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients

BACKGROUND: Several studies have found that Cathepsin B (CTSB) is up-regulated in many tumor types and facilitates tumor progression. However, the role of CTSB in hepatocellular carcinoma (HCC) progression remains unclear. This study was aimed at investigating the expression and role of CTSB in HCC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruan, Jian, Zheng, Haiyan, Rong, Xiaodong, Rong, Xiaomin, Zhang, Junyi, Fang, Weijia, Zhao, Peng, Luo, Rongcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761221/
https://www.ncbi.nlm.nih.gov/pubmed/26896959
http://dx.doi.org/10.1186/s12943-016-0503-9
_version_ 1782416954153238528
author Ruan, Jian
Zheng, Haiyan
Rong, Xiaodong
Rong, Xiaomin
Zhang, Junyi
Fang, Weijia
Zhao, Peng
Luo, Rongcheng
author_facet Ruan, Jian
Zheng, Haiyan
Rong, Xiaodong
Rong, Xiaomin
Zhang, Junyi
Fang, Weijia
Zhao, Peng
Luo, Rongcheng
author_sort Ruan, Jian
collection PubMed
description BACKGROUND: Several studies have found that Cathepsin B (CTSB) is up-regulated in many tumor types and facilitates tumor progression. However, the role of CTSB in hepatocellular carcinoma (HCC) progression remains unclear. This study was aimed at investigating the expression and role of CTSB in HCC in a large set of samples and cell lines (MHCC-97H and MHCC-97 L), and evaluating the clinical and prognostic significance of CTSB protein in patients with HCC. METHODS: The expression of CTSB was examined in HCC tissue and cell lines by Western-blotting, Real-time PCR, and immunohistochemical staining. Wound healing assay and invasion assay were used to verify the effect of CTSB on the migration and invasion ability of HCC cell lines. Tumor formation assay in nude mice was used to analyze the effect of CTSB on the tumorigenicity of HCC cell lines. RESULTS: The status of CTSB protein in carcinoma tissues is much higher than that in paracarcinoma tissues. The overall survival of the patients with high CTSB expression was significantly shorter than the low CTSB expression group. High CTSB expression was significantly correlated with advanced clinical staging, histological grade, and tumor recurrence. In vitro and in vivo experiments demonstrated that over-expression of CTSB in MHCC-97 L cells promoted cell invasion and tumor progression ability. Down-regulation of CTSB in MHCC-97H showed the opposite effects. These phenotypic changes caused by CTSB knockdown or over-expression correlated with expression of the matrix metallopeptidase MMP-9. Moreover, multivariate analysis suggested that CTSB expression might be an independent prognostic indicator for the survival of HCC patients after curative surgery. CONCLUSIONS: CTSB might be involved in the development and progression of HCC as an oncogene, and thereby may be a valuable prognostic marker for HCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0503-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4761221
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47612212016-02-21 Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients Ruan, Jian Zheng, Haiyan Rong, Xiaodong Rong, Xiaomin Zhang, Junyi Fang, Weijia Zhao, Peng Luo, Rongcheng Mol Cancer Research BACKGROUND: Several studies have found that Cathepsin B (CTSB) is up-regulated in many tumor types and facilitates tumor progression. However, the role of CTSB in hepatocellular carcinoma (HCC) progression remains unclear. This study was aimed at investigating the expression and role of CTSB in HCC in a large set of samples and cell lines (MHCC-97H and MHCC-97 L), and evaluating the clinical and prognostic significance of CTSB protein in patients with HCC. METHODS: The expression of CTSB was examined in HCC tissue and cell lines by Western-blotting, Real-time PCR, and immunohistochemical staining. Wound healing assay and invasion assay were used to verify the effect of CTSB on the migration and invasion ability of HCC cell lines. Tumor formation assay in nude mice was used to analyze the effect of CTSB on the tumorigenicity of HCC cell lines. RESULTS: The status of CTSB protein in carcinoma tissues is much higher than that in paracarcinoma tissues. The overall survival of the patients with high CTSB expression was significantly shorter than the low CTSB expression group. High CTSB expression was significantly correlated with advanced clinical staging, histological grade, and tumor recurrence. In vitro and in vivo experiments demonstrated that over-expression of CTSB in MHCC-97 L cells promoted cell invasion and tumor progression ability. Down-regulation of CTSB in MHCC-97H showed the opposite effects. These phenotypic changes caused by CTSB knockdown or over-expression correlated with expression of the matrix metallopeptidase MMP-9. Moreover, multivariate analysis suggested that CTSB expression might be an independent prognostic indicator for the survival of HCC patients after curative surgery. CONCLUSIONS: CTSB might be involved in the development and progression of HCC as an oncogene, and thereby may be a valuable prognostic marker for HCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-016-0503-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-20 /pmc/articles/PMC4761221/ /pubmed/26896959 http://dx.doi.org/10.1186/s12943-016-0503-9 Text en © Ruan et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ruan, Jian
Zheng, Haiyan
Rong, Xiaodong
Rong, Xiaomin
Zhang, Junyi
Fang, Weijia
Zhao, Peng
Luo, Rongcheng
Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
title Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
title_full Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
title_fullStr Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
title_full_unstemmed Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
title_short Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
title_sort over-expression of cathepsin b in hepatocellular carcinomas predicts poor prognosis of hcc patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761221/
https://www.ncbi.nlm.nih.gov/pubmed/26896959
http://dx.doi.org/10.1186/s12943-016-0503-9
work_keys_str_mv AT ruanjian overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients
AT zhenghaiyan overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients
AT rongxiaodong overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients
AT rongxiaomin overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients
AT zhangjunyi overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients
AT fangweijia overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients
AT zhaopeng overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients
AT luorongcheng overexpressionofcathepsinbinhepatocellularcarcinomaspredictspoorprognosisofhccpatients